secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2024-04-04T23:59:59+00:00
Accession:  0000950170-24-041613
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical preliminary Q1 net sales >$77M; record US ICL sales of $5M, up 20% sequentially
--------------------------------------------------------------------------------

- Preliminary Q1 2024 net sales in excess of $77M; US ICL sales hit record $5M, up ~20% sequentially.
- EMEA ICL sales up ~11% YoY; APAC ICL sales up ~9% including ~10% growth in China.
- Cash and investments ~$248M (Dec 2023: $232.4M); accounts receivable ~$70M (Dec 2023: $94.7M).
- Fiscal 2024 net sales outlook now expected at higher end of $335M-$340M range.
- Full Q1 results and 2024 outlook to be discussed on earnings call on/about May 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017024041613/0000950170-24-041613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017024041613/staa-20240404.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-041613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer